Open AccessRisks of testosterone replacement therapy in men
Author(s) -
E. Charles Osterberg,
Aaron Bernie,
Ranjith Ramasamy
Publication year - 2014
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/0970-1591.124197
Subject(s) - medicine , libido , testosterone replacement , prostate cancer , testosterone (patch) , hormone replacement therapy (female to male) , erectile dysfunction , urology , oncology , cardiology , cancer , androgen , hormone
Testosterone replacement therapy (TRT) is a widely used treatment for men with symptomatic hypogonadism. The benefits seen with TRT, such as increased libido and energy level, beneficial effects on bone density, strength and muscle as well as cardioprotective effects, have been well-documented. TRT is contraindicated in men with untreated prostate and breast cancer. Men on TRT should be monitored for side-effects such as polycythemia, peripheral edema, cardiac and hepatic dysfunction.